GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » Other Long Term Assets

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Other Long Term Assets : NT$30.63 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals Other Long Term Assets?

Great Novel Therapeutics Biotech & Medicals's other long-term assets for the quarter that ended in Dec. 2023 was NT$30.63 Mil.

Great Novel Therapeutics Biotech & Medicals's quarterly other long-term assets increased from Dec. 2022 (NT$21.87 Mil) to Jun. 2023 (NT$26.92 Mil) and increased from Jun. 2023 (NT$26.92 Mil) to Dec. 2023 (NT$30.63 Mil).

Great Novel Therapeutics Biotech & Medicals's annual other long-term assets increased from Dec. 2021 (NT$15.84 Mil) to Dec. 2022 (NT$21.87 Mil) and increased from Dec. 2022 (NT$21.87 Mil) to Dec. 2023 (NT$30.63 Mil).


Great Novel Therapeutics Biotech & Medicals Other Long Term Assets Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals Other Long Term Assets Chart

Great Novel Therapeutics Biotech & Medicals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial 4.65 9.65 15.84 21.87 30.63

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.84 19.68 21.87 26.92 30.63

Great Novel Therapeutics Biotech & Medicals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Traded in Other Exchanges
N/A
Address
No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503
Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines